Historical milestones in the development of tibolone (Livial®)

Author： Kloosterboer H. J.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.14, Iss.6, 2011-12, pp. : 609-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why tibolone is different?

By Rymer J.  

Reviews in Gynaecological Practice, Vol. 2, Iss. 1, 2002-09 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Effects of tibolone on the breast

By Colacurci N.   Mele D.   De Franciscis P.   Costa V.   Fortunato N.   De Seta L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 80, Iss. 2, 1998-10 ,pp. : 235-238

Elsevier

Access to resources Recommend Favorite

What is tibolone – and is it a SPEAR?

By Purdie D. W.  

Climacteric, Vol. 5, Iss. 3, 2002-09 ,pp. : 236-239

Informa Healthcare

Access to resources Recommend Favorite

Tibolone is not aromatized in postmenopausal women

By  

Climacteric, Vol. 11, Iss. 2, 2008-01 ,pp. : 175-176

Informa Healthcare

Access to resources Recommend Favorite

Effects of tibolone on the endometrium

By Völker W.   Coelingh Bennink H. J. T.   Helmond F. A.  

Climacteric, Vol. 4, Iss. 3, 2001-09 ,pp. : 203-208

Informa Healthcare

Access to resources Recommend Favorite